Table 1

Demographics and comorbidities for patients across total patient population diagnosed with heart failure in NWL in 2015–2020 (n=34 208) and PSM cohort (n=8582 for each of hospital and community pathway)

Total population (n=34 208)P valuePropensity-matched cohort (n=17 212)P value
Community pathwayHospital pathwayCommunity pathway (n=8582)Hospital pathway (n=8582)
Age (SD)72.26±13.5073.84± (13.33)<0.000173.53±12.1873.61±12.620.66
Male gender (%)5007 (46.0)11 895 (51.1)<0.00014644 (54.1)4626 (53.9)0.79
IMD (SD)5.02±2.304.83±2.31<0.00016.63±2.286.68±2.310.13
Ethnicity<0.00010.92
Asian or Asian British (%)2994 (27.5)5913 (25.4)2591 (30.2)2567 (29.9)
Black or Black British (%)948 (8.7)1961 (8.4)787 (9.2)807 (9.4)
Mixed (%)181 (1.7)433 (1.9)148 (1.7)136 (1.6)
Other ethnic groups (%)456 (4.2)912 (3.9)363 (4.2)367 (4.3)
White (%)5539 (50.9)12 000 (51.5)4693 (54.7)4705 (54.8)
Unknown ethnicity (%)767 (7.1)2104 (9.0)
COPD (%)1633 (15.0)4234 (18.2)< 0.00011470 (17.1)1440 (16.8)0.56
AF (%)3592 (33.0)7763 (33.3)0.6018512498 (29.1)2571 (30.0)0.23
CKD (%)2939 (27.0)6822 (29.3)<0.00012338 (27.2)2323 (27.1)0.81
IHD (%)4027 (37.0)8704 (37.3)0.5642313862 (45.0)3935 (45.9)0.27
Stroke (%)1013 (9.3)2733 (11.7)<0.0001899 (10.5)889 (10.4)0.82
Ventricular arrhythmia (%)130 (1.2)281 (1.2)0.933738104 (1.2)105 (1.2)1.00
T2DM (%)3592 (33.0)8233 (35.3)<0.00013099 (36.1)3040 (35.4)0.36
Hypertension (%)7293 (67.0)15 055 (64.6)<0.00017001 (81.6)6994 (81.5)0.91
  • AF, atrial fibrillation; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; IMD, index of multiple deprivation; NWL, north west London; PSM, propensity score-matched; T2DM, type 2 diabetes mellitus.